NASDAQ:VINC

Vincerx Pharma Stock Forecast, Price & News

$19.06

-0.18 (-0.94 %)

(As of 04/9/2021 12:00 AM ET)

Add

Compare

Today's Range

$18.85

Now: $19.06▼

$19.58

50-Day Range

$18.13

MA: $20.31▼

$25.90

52-Week Range

$9.35

Now: $19.06▼

$26.75

Volume28,643 shs

Average Volume99,351 shs

Market Capitalization$156.39 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops new therapies to address unmet medical needs for the treatment of cancer. The company's lead product candidate is VIP152 that is in clinical trials. Its drug candidates are in development for the treatment of solid tumors, leukemia, B-cell malignancies, lymphomas, and myelodysplastic syndrome. Vincerx Pharma, Inc. is based in Palo Alto, California.

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Biotechnology

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:VINC

Previous Symbol

CUSIPN/A

CIKN/A

Webvincerapharma.com

Phone650 800 6676

Employees28

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares8,205,000

Market Cap$156.39 million

Next Earnings DateN/A

OptionableNot Optionable

Headlines

No headlines for this company have been tracked by MarketBeat.com

MarketRank^™

Overall MarketRank^™

1.00 out of 5 stars

Medical Sector

1065th out of 2,010 stocks

Biotechnology Industry

46th out of 143 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Vincerx Pharma.

5.0 Community Rank

Outperform Votes
Vincerx Pharma has received 1 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Vincerx Pharma has received 0 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Vincerx Pharma has received 100.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Vincerx Pharma and other stocks. Vote “Outperform” if you believe VINC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe VINC will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Vincerx Pharma does not currently pay a dividend.
Dividend Growth
Vincerx Pharma does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Vincerx Pharma insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

$19.06

-0.18 (-0.94 %)

(As of 04/9/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive VINC News and Ratings via Email

Sign-up to receive the latest news and ratings for VINC and its competitors with MarketBeat's FREE daily newsletter.

Vincerx Pharma (NASDAQ:VINC) Frequently Asked Questions

Is Vincerx Pharma a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Vincerx Pharma in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Vincerx Pharma stock.
View analyst ratings for Vincerx Pharma or view top-rated stocks.

What stocks does MarketBeat like better than Vincerx Pharma?

Wall Street analysts have given Vincerx Pharma a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Vincerx Pharma wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are Vincerx Pharma's key executives?

Vincerx Pharma's management team includes the following people:

Dr. Ahmed M. Hamdy, Founder, Chairman & CEO (Age 56, Pay $622.05k)
Dr. Raquel E. Izumi, Founder, Pres, COO, Sec. & Director (Age 51, Pay $652.84k)
Mr. Alexander A. Seelenberger M.B.A., MBA, Chief Financial Officer (Age 42, Pay $405.46k)
Mr. Stuart Hwang Ph.D., Chief Bus. Officer & Founder
Mr. Tom C. Thomas, Founder, Gen. Counsel & Chief Legal Officer
Dr. John C. Byrd M.D., Founder
Dr. Xiaoming Zhang Ph.D., Chief Technical Officer (Age 57)
Dr. Hans-Georg Lerchen Ph.D., Chief Scientific Officer
Dr. Hermes Garban M.D., Ph.D., Chief Medical Officer
Dr. David Nganele M.B.A., Ph.D., Head of Early Devel.

Who are some of Vincerx Pharma's key competitors?

Some companies that are related to Vincerx Pharma include Aptose Biosciences (APS), Biotest Aktiengesellschaft (BIO), Burcon NutraScience (BU), Gemini Therapeutics (GMTX), Sigilon Therapeutics (SGTX), Inventiva (IVA), 22nd Century Group (XXII), Ergomed (ERGO), Silence Therapeutics (SLN), Terns Pharmaceuticals (TERN), Angion Biomedica (ANGN), Theratechnologies (TH), Pfenex (PFNX), Sensei Biotherapeutics (SNSE) and BELLUS Health (BLU).
View all of VINC's competitors.

What is Vincerx Pharma's stock symbol?

Vincerx Pharma trades on the NASDAQ under the ticker symbol "VINC."

How do I buy shares of Vincerx Pharma?

Shares of VINC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Vincerx Pharma's stock price today?

One share of VINC stock can currently be purchased for approximately $19.06.

How much money does Vincerx Pharma make?

Vincerx Pharma has a market capitalization of $156.39 million.

How many employees does Vincerx Pharma have?

Vincerx Pharma employs 28 workers across the globe.

What is Vincerx Pharma's official website?

The official website for Vincerx Pharma is vincerapharma.com.

How can I contact Vincerx Pharma?

The company can be reached via phone at 650 800 6676.

This page was last updated on 4/10/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Vincerx Pharma Stock Forecast, Price & News

Adding

Adding

Adding Vincerx Pharma, Inc.

Industry, Sector and Symbol

Debt

Price-To-Earnings

Sales & Book Value

Profitability

Miscellaneous

Headlines

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

5.0 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment